Advertisement

Topics

Jubilant Biosys Becomes the First Company in India to Install Agilent's RapidFire/MS Screening Platform

06:12 EDT 19 Oct 2016 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
BENGALURU, October 19, 2016 /PRNewswire/ -- Jubilant Biosys is proud to announce the addition of Agilent Technologies' RapidFire/MS screening technology to its Integrated Drug Discovery Platform.      (Logo: http://photos.prnews...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Jubilant Biosys Becomes the First Company in India to Install Agilent's RapidFire/MS Screening Platform"

Quick Search
Advertisement
 

Relevant Topics

Immunoassay - ELISA
Immunoassays are quick and accurate tests to detect specific molecules. Immunoassays rely on an antibody to bind to the specific structure of a molecule. Antibodies are proteins generated by animals in response to the invasion of a foreign molecule (anti...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Antiretroviral therapy
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...